iRhythm raises 2026 guidance on third-quarter revenue and margin growth
iRhythm's third-quarter revenue rose 14.9% year on year to $221.6M, and the company lifted its 2026 outlook to include VitalConnect, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, iRhythm Technologies' third-quarter revenue grew 14.9% year on year to $221.6 million. Adjusted EBITDA margin reached 23.1%, and gross margin stood at 74.2%.
The company raised its full-year 2026 revenue guidance to a range of $890 million to $895 million. The forecast includes the expected contribution from VitalConnect, the company it acquired. Adjusted EBITDA margin guidance was set at 15.5% to 16.0%.
why it matters
Investors will note the combination of faster revenue growth, high margins and a higher outlook. It suggests the business is still expanding after integrating the newly acquired company, and the market will watch whether the growth pace holds.
market impact
iRhythm shares: higher guidance and margin gains support expectations for the business
- iRhythm shares pressure up — higher guidance and margin gains improve expectations for the business
tags
instruments
sources
- IRTC: Q3 growth and margin expansion lifted FY 2026 guidance — TradingView, 5 November 2026 at 21:08 UTC
- IRTC: Revenue growth and margin expansion lifted FY2026 guidance after the VitalConnect acquisition — TradingView, 5 November 2026 at 21:32 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗